APO Research
Talk to an analyst

APO RESEARCH · REPORT

Latanoprost

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.

In the report, one unit refers to one bottle.

Selected research

Market Analysis & Forecast

Global Latanoprost Market Analysis and Forecast 2026-2032

21 December 2025197 pages

Choose your research edition.

Industry ResearchLatanoprost Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Latanoprost Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Latanoprost Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Latanoprost Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Latanoprost Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.

In the report, one unit refers to one bottle.

Read the full market overview

Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.

This report presents an overview of global market for Latanoprost, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Latanoprost, also provides the sales of main regions and countries. Of the upcoming market potential for Latanoprost, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Latanoprost sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Latanoprost market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Latanoprost sales, projected growth trends, production technology, application and end-user industry.

Latanoprost Segment by Company

Pfizer

Mylan

Novartis

Apotex

Teva

Taj Pharma

CR Zizhu

Latanoprost Segment by Type

Brand Drug

Generic Drug

Latanoprost Segment by Application

Open-angle Glaucoma

Close-angle Glaucoma

Latanoprost Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latanoprost market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Latanoprost and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latanoprost.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Latanoprost in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Latanoprost manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Latanoprost sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Latanoprost Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Brand Drug Major Manufacturers Table 3. Generic Drug Major Manufacturers Table 4. Global Latanoprost Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Open-angle Glaucoma Major Manufacturers Table 6. Close-angle Glaucoma Major Manufacturers Table 7. Latanoprost Industry Trends Table 8. Latanoprost Industry Drivers Table 9. Latanoprost Industry Opportunities and Challenges Table 10. Latanoprost Industry Restraints Table 11. Global Latanoprost Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Latanoprost Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Latanoprost Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Latanoprost Revenue Market Share by Region (2021-2026) Table 15. Global Latanoprost Revenue Market Share by Region (2027-2032) Table 16. Global Latanoprost Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Unit) Table 17. Global Latanoprost Sales by Region (2021-2026) & (M Unit) Table 18. Global Latanoprost Sales by Region (2027-2032) & (M Unit) Table 19. Global Latanoprost Sales Market Share by Region (2021-2026) Table 20. Global Latanoprost Sales Market Share by Region (2027-2032) Table 21. Global Latanoprost Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Latanoprost Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Latanoprost Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Latanoprost Sales Market Share by Manufacturers (2021-2026) Table 25. Global Latanoprost Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 26. Global Latanoprost Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Latanoprost Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Latanoprost Manufacturers, Product Type & Application Table 29. Global Latanoprost Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Latanoprost by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Latanoprost Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Latanoprost Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Latanoprost Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Latanoprost Revenue Market Share by Type (2021-2026) Table 36. Global Latanoprost Revenue Market Share by Type (2027-2032) Table 37. Global Latanoprost Sales by Type 2021 VS 2025 VS 2032 (M Unit) Table 38. Global Latanoprost Sales by Type (2021-2026) & (M Unit) Table 39. Global Latanoprost Sales by Type (2027-2032) & (M Unit) Table 40. Global Latanoprost Sales Market Share by Type (2021-2026) Table 41. Global Latanoprost Sales Market Share by Type (2027-2032) Table 42. Global Latanoprost Price by Type (2021-2026) & (USD/Unit) Table 43. Global Latanoprost Price by Type (2027-2032) & (USD/Unit) Table 44. Global Latanoprost Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Latanoprost Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Latanoprost Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Latanoprost Revenue Market Share by Application (2021-2026) Table 48. Global Latanoprost Revenue Market Share by Application (2027-2032) Table 49. Global Latanoprost Sales by Application 2021 VS 2025 VS 2032 (M Unit) Table 50. Global Latanoprost Sales by Application (2021-2026) & (M Unit) Table 51. Global Latanoprost Sales by Application (2027-2032) & (M Unit) Table 52. Global Latanoprost Sales Market Share by Application (2021-2026) Table 53. Global Latanoprost Sales Market Share by Application (2027-2032) Table 54. Global Latanoprost Price by Application (2021-2026) & (USD/Unit) Table 55. Global Latanoprost Price by Application (2027-2032) & (USD/Unit) Table 56. Pfizer Company Information Table 57. Pfizer Business Overview Table 58. Pfizer Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 59. Pfizer Latanoprost Product Portfolio Table 60. Pfizer Recent Development Table 61. Mylan Company Information Table 62. Mylan Business Overview Table 63. Mylan Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 64. Mylan Latanoprost Product Portfolio Table 65. Mylan Recent Development Table 66. Novartis Company Information Table 67. Novartis Business Overview Table 68. Novartis Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 69. Novartis Latanoprost Product Portfolio Table 70. Novartis Recent Development Table 71. Apotex Company Information Table 72. Apotex Business Overview Table 73. Apotex Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Apotex Latanoprost Product Portfolio Table 75. Apotex Recent Development Table 76. Teva Company Information Table 77. Teva Business Overview Table 78. Teva Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Teva Latanoprost Product Portfolio Table 80. Teva Recent Development Table 81. Taj Pharma Company Information Table 82. Taj Pharma Business Overview Table 83. Taj Pharma Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Taj Pharma Latanoprost Product Portfolio Table 85. Taj Pharma Recent Development Table 86. CR Zizhu Company Information Table 87. CR Zizhu Business Overview Table 88. CR Zizhu Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. CR Zizhu Latanoprost Product Portfolio Table 90. CR Zizhu Recent Development Table 91. North America Latanoprost Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Latanoprost Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Latanoprost Sales by Type (2021-2026) & (M Unit) Table 94. North America Latanoprost Sales by Type (2027-2032) & (M Unit) Table 95. North America Latanoprost Sales Price by Type (2021-2026) & (USD/Unit) Table 96. North America Latanoprost Sales Price by Type (2027-2032) & (USD/Unit) Table 97. North America Latanoprost Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Latanoprost Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Latanoprost Sales by Application (2021-2026) & (M Unit) Table 100. North America Latanoprost Sales by Application (2027-2032) & (M Unit) Table 101. North America Latanoprost Sales Price by Application (2021-2026) & (USD/Unit) Table 102. North America Latanoprost Sales Price by Application (2027-2032) & (USD/Unit) Table 103. North America Latanoprost Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Latanoprost Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. North America Latanoprost Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. North America Latanoprost Sales by Country (2021 VS 2025 VS 2032) & (M Unit) Table 107. North America Latanoprost Sales by Country (2021-2026) & (M Unit) Table 108. North America Latanoprost Sales by Country (2027-2032) & (M Unit) Table 109. North America Latanoprost Sales Price by Country (2021-2026) & (USD/Unit) Table 110. North America Latanoprost Sales Price by Country (2027-2032) & (USD/Unit) Table 111. United States Latanoprost Revenue (2021-2032) & (US$ Million) Table 112. Canada Latanoprost Revenue (2021-2032) & (US$ Million) Table 113. Mexico Latanoprost Revenue (2021-2032) & (US$ Million) Table 114. Europe Latanoprost Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe Latanoprost Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe Latanoprost Sales by Type (2021-2026) & (M Unit) Table 117. Europe Latanoprost Sales by Type (2027-2032) & (M Unit) Table 118. Europe Latanoprost Sales Price by Type (2021-2026) & (USD/Unit) Table 119. Europe Latanoprost Sales Price by Type (2027-2032) & (USD/Unit) Table 120. Europe Latanoprost Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Latanoprost Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Latanoprost Sales by Application (2021-2026) & (M Unit) Table 123. Europe Latanoprost Sales by Application (2027-2032) & (M Unit) Table 124. Europe Latanoprost Sales Price by Application (2021-2026) & (USD/Unit) Table 125. Europe Latanoprost Sales Price by Application (2027-2032) & (USD/Unit) Table 126. Europe Latanoprost Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Latanoprost Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 128. Europe Latanoprost Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 129. Europe Latanoprost Sales by Country (2021 VS 2025 VS 2032) & (M Unit) Table 130. Europe Latanoprost Sales by Country (2021-2026) & (M Unit) Table 131. Europe Latanoprost Sales by Country (2027-2032) & (M Unit) Table 132. Europe Latanoprost Sales Price by Country (2021-2026) & (USD/Unit) Table 133. Europe Latanoprost Sales Price by Country (2027-2032) & (USD/Unit) Table 134. Germany Latanoprost Revenue (2021-2032) & (US$ Million) Table 135. France Latanoprost Revenue (2021-2032) & (US$ Million) Table 136. U.K. Latanoprost Revenue (2021-2032) & (US$ Million) Table 137. Italy Latanoprost Revenue (2021-2032) & (US$ Million) Table 138. Russia Latanoprost Revenue (2021-2032) & (US$ Million) Table 139. Spain Latanoprost Revenue (2021-2032) & (US$ Million) Table 140. Netherlands Latanoprost Revenue (2021-2032) & (US$ Million) Table 141. Switzerland Latanoprost Revenue (2021-2032) & (US$ Million) Table 142. Sweden Latanoprost Revenue (2021-2032) & (US$ Million) Table 143. Poland Latanoprost Revenue (2021-2032) & (US$ Million) Table 144. China Latanoprost Revenue by Type (2021-2026) & (US$ Million) Table 145. China Latanoprost Revenue by Type (2027-2032) & (US$ Million) Table 146. China Latanoprost Sales by Type (2021-2026) & (M Unit) Table 147. China Latanoprost Sales by Type (2027-2032) & (M Unit) Table 148. China Latanoprost Sales Price by Type (2021-2026) & (USD/Unit) Table 149. China Latanoprost Sales Price by Type (2027-2032) & (USD/Unit) Table 150. China Latanoprost Revenue by Application (2021-2026) & (US$ Million) Table 151. China Latanoprost Revenue by Application (2027-2032) & (US$ Million) Table 152. China Latanoprost Sales by Application (2021-2026) & (M Unit) Table 153. China Latanoprost Sales by Application (2027-2032) & (M Unit) Table 154. China Latanoprost Sales Price by Application (2021-2026) & (USD/Unit) Table 155. China Latanoprost Sales Price by Application (2027-2032) & (USD/Unit) Table 156. Asia Latanoprost Revenue by Type (2021-2026) & (US$ Million) Table 157. Asia Latanoprost Revenue by Type (2027-2032) & (US$ Million) Table 158. Asia Latanoprost Sales by Type (2021-2026) & (M Unit) Table 159. Asia Latanoprost Sales by Type (2027-2032) & (M Unit) Table 160. Asia Latanoprost Sales Price by Type (2021-2026) & (USD/Unit) Table 161. Asia Latanoprost Sales Price by Type (2027-2032) & (USD/Unit) Table 162. Asia Latanoprost Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia Latanoprost Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia Latanoprost Sales by Application (2021-2026) & (M Unit) Table 165. Asia Latanoprost Sales by Application (2027-2032) & (M Unit) Table 166. Asia Latanoprost Sales Price by Application (2021-2026) & (USD/Unit) Table 167. Asia Latanoprost Sales Price by Application (2027-2032) & (USD/Unit) Table 168. Asia Latanoprost Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Asia Latanoprost Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Asia Latanoprost Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Asia Latanoprost Sales by Country (2021 VS 2025 VS 2032) & (M Unit) Table 172. Asia Latanoprost Sales by Country (2021-2026) & (M Unit) Table 173. Asia Latanoprost Sales by Country (2027-2032) & (M Unit) Table 174. Asia Latanoprost Sales Price by Country (2021-2026) & (USD/Unit) Table 175. Asia Latanoprost Sales Price by Country (2027-2032) & (USD/Unit) Table 176. Japan Latanoprost Revenue (2021-2032) & (US$ Million) Table 177. South Korea Latanoprost Revenue (2021-2032) & (US$ Million) Table 178. India Latanoprost Revenue (2021-2032) & (US$ Million) Table 179. Australia Latanoprost Revenue (2021-2032) & (US$ Million) Table 180. Taiwan Latanoprost Revenue (2021-2032) & (US$ Million) Table 181. Southeast Asia Latanoprost Revenue (2021-2032) & (US$ Million) Table 182. SAMEA Latanoprost Revenue by Type (2021-2026) & (US$ Million) Table 183. SAMEA Latanoprost Revenue by Type (2027-2032) & (US$ Million) Table 184. SAMEA Latanoprost Sales by Type (2021-2026) & (M Unit) Table 185. SAMEA Latanoprost Sales by Type (2027-2032) & (M Unit) Table 186. SAMEA Latanoprost Sales Price by Type (2021-2026) & (USD/Unit) Table 187. SAMEA Latanoprost Sales Price by Type (2027-2032) & (USD/Unit) Table 188. SAMEA Latanoprost Revenue by Application (2021-2026) & (US$ Million) Table 189. SAMEA Latanoprost Revenue by Application (2027-2032) & (US$ Million) Table 190. SAMEA Latanoprost Sales by Application (2021-2026) & (M Unit) Table 191. SAMEA Latanoprost Sales by Application (2027-2032) & (M Unit) Table 192. SAMEA Latanoprost Sales Price by Application (2021-2026) & (USD/Unit) Table 193. SAMEA Latanoprost Sales Price by Application (2027-2032) & (USD/Unit) Table 194. SAMEA Latanoprost Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. SAMEA Latanoprost Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. SAMEA Latanoprost Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. SAMEA Latanoprost Sales by Country (2021 VS 2025 VS 2032) & (M Unit) Table 198. SAMEA Latanoprost Sales by Country (2021-2026) & (M Unit) Table 199. SAMEA Latanoprost Sales by Country (2027-2032) & (M Unit) Table 200. SAMEA Latanoprost Sales Price by Country (2021-2026) & (USD/Unit) Table 201. SAMEA Latanoprost Sales Price by Country (2027-2032) & (USD/Unit) Table 202. Brazil Latanoprost Revenue (2021-2032) & (US$ Million) Table 203. Argentina Latanoprost Revenue (2021-2032) & (US$ Million) Table 204. Chile Latanoprost Revenue (2021-2032) & (US$ Million) Table 205. Colombia Latanoprost Revenue (2021-2032) & (US$ Million) Table 206. Peru Latanoprost Revenue (2021-2032) & (US$ Million) Table 207. Saudi Arabia Latanoprost Revenue (2021-2032) & (US$ Million) Table 208. Israel Latanoprost Revenue (2021-2032) & (US$ Million) Table 209. UAE Latanoprost Revenue (2021-2032) & (US$ Million) Table 210. Turkey Latanoprost Revenue (2021-2032) & (US$ Million) Table 211. Iran Latanoprost Revenue (2021-2032) & (US$ Million) Table 212. Egypt Latanoprost Revenue (2021-2032) & (US$ Million) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. Latanoprost Distributors List Table 216. Latanoprost Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. Latanoprost Image Figure 2. Global Latanoprost Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Latanoprost Market Size Share 2021 VS 2025 VS 2032 Figure 4. Brand Drug Image Figure 5. Generic Drug Image Figure 6. Global Latanoprost Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Latanoprost Market Size Share 2021 VS 2025 VS 2032 Figure 8. Open-angle Glaucoma Image Figure 9. Close-angle Glaucoma Image Figure 10. Global Latanoprost Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Latanoprost Revenue (2021-2032) & (US$ Million) Figure 12. Global Latanoprost Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Latanoprost Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Latanoprost Revenue Market Share by Region (2021-2032) Figure 15. Global Latanoprost Sales (2021-2032) & (M Unit) Figure 16. Global Latanoprost Sales by Region: 2021 VS 2025 VS 2032 (M Unit) Figure 17. Global Latanoprost Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Latanoprost Sales YoY (2021-2032) & (M Unit) Figure 19. Europe Latanoprost Sales YoY (2021-2032) & (M Unit) Figure 20. China Latanoprost Sales YoY (2021-2032) & (M Unit) Figure 21. Asia (Excluding China) Latanoprost Sales YoY (2021-2032) & (M Unit) Figure 22. South America, Middle East and Africa Latanoprost Sales YoY (2021-2032) & (M Unit) Figure 23. Global Latanoprost Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Latanoprost Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Latanoprost Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Latanoprost Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Latanoprost Revenue Market Share by Type (2021-2032) Figure 29. Global Latanoprost Sales by Type (2021 VS 2025 VS 2032) & (M Unit) Figure 30. Global Latanoprost Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Latanoprost Sales Market Share by Type (2021-2032) Figure 32. Global Latanoprost Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Latanoprost Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Latanoprost Revenue Market Share by Application (2021-2032) Figure 35. Global Latanoprost Sales by Application (2021 VS 2025 VS 2032) & (M Unit) Figure 36. Global Latanoprost Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Latanoprost Sales Market Share by Application (2021-2032) Figure 38. North America Latanoprost Revenue Share by Type (2021-2032) Figure 39. North America Latanoprost Sales Share by Type (2021-2032) Figure 40. North America Latanoprost Revenue Share by Application (2021-2032) Figure 41. North America Latanoprost Sales Share by Application (2021-2032) Figure 42. North America Latanoprost Revenue Share by Country (2021-2032) Figure 43. North America Latanoprost Sales Share by Country (2021-2032) Figure 44. Europe Latanoprost Revenue Share by Type (2021-2032) Figure 45. Europe Latanoprost Sales Share by Type (2021-2032) Figure 46. Europe Latanoprost Revenue Share by Application (2021-2032) Figure 47. Europe Latanoprost Sales Share by Application (2021-2032) Figure 48. Europe Latanoprost Revenue Share by Country (2021-2032) Figure 49. Europe Latanoprost Sales Share by Country (2021-2032) Figure 50. China Latanoprost Revenue Share by Type (2021-2032) Figure 51. China Latanoprost Sales Share by Type (2021-2032) Figure 52. China Latanoprost Revenue Share by Application (2021-2032) Figure 53. China Latanoprost Sales Share by Application (2021-2032) Figure 54. Asia Latanoprost Revenue Share by Type (2021-2032) Figure 55. Asia Latanoprost Sales Share by Type (2021-2032) Figure 56. Asia Latanoprost Revenue Share by Application (2021-2032) Figure 57. Asia Latanoprost Sales Share by Application (2021-2032) Figure 58. Asia Latanoprost Revenue Share by Country (2021-2032) Figure 59. Asia Latanoprost Sales Share by Country (2021-2032) Figure 60. SAMEA Latanoprost Revenue Share by Type (2021-2032) Figure 61. SAMEA Latanoprost Sales Share by Type (2021-2032) Figure 62. SAMEA Latanoprost Revenue Share by Application (2021-2032) Figure 63. SAMEA Latanoprost Sales Share by Application (2021-2032) Figure 64. SAMEA Latanoprost Revenue Share by Country (2021-2032) Figure 65. SAMEA Latanoprost Sales Share by Country (2021-2032) Figure 66. Latanoprost Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Latanoprost Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Brand Drug
  • Generic Drug
Applications
  • Open-angle Glaucoma
  • Close-angle Glaucoma
Companies covered
  • Pfizer
  • Mylan
  • Novartis
  • Apotex
  • Teva
  • Taj Pharma
  • CR Zizhu

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Latanoprost Market by Type
  3. 1.2.1 Global Latanoprost Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Brand Drug
  5. 1.2.3 Generic Drug
  6. 1.3 Latanoprost Market by Application
  7. 1.3.1 Global Latanoprost Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Open-angle Glaucoma
  9. 1.3.3 Close-angle Glaucoma
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Latanoprost Market Dynamics
  1. 2.1 Latanoprost Industry Trends
  2. 2.2 Latanoprost Industry Drivers
  3. 2.3 Latanoprost Industry Opportunities and Challenges
  4. 2.4 Latanoprost Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Latanoprost Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Latanoprost Revenue by Region
  3. 3.2.1 Global Latanoprost Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Latanoprost Revenue by Region (2021-2026)
  5. 3.2.3 Global Latanoprost Revenue by Region (2027-2032)
  6. 3.2.4 Global Latanoprost Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Latanoprost Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Latanoprost Sales by Region
  9. 3.4.1 Global Latanoprost Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Latanoprost Sales by Region (2021-2026)
  11. 3.4.3 Global Latanoprost Sales by Region (2027-2032)
  12. 3.4.4 Global Latanoprost Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Latanoprost Revenue by Manufacturers
  2. 4.1.1 Global Latanoprost Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Latanoprost Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Latanoprost Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Latanoprost Sales by Manufacturers
  6. 4.2.1 Global Latanoprost Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Latanoprost Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Latanoprost Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Latanoprost Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Latanoprost Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Latanoprost Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Latanoprost Manufacturers, Product Type & Application
  13. 4.7 Global Latanoprost Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Latanoprost Market CR5 and HHI
  16. 4.8.2 2025 Latanoprost Tier 1, Tier 2, and Tier 3
5 Latanoprost Market by Type
  1. 5.1 Global Latanoprost Revenue by Type
  2. 5.1.1 Global Latanoprost Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Latanoprost Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Latanoprost Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Latanoprost Sales by Type
  6. 5.2.1 Global Latanoprost Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Latanoprost Sales by Type (2021-2032) & (M Unit)
  8. 5.2.3 Global Latanoprost Sales Market Share by Type (2021-2032)
  9. 5.3 Global Latanoprost Price by Type
6 Latanoprost Market by Application
  1. 6.1 Global Latanoprost Revenue by Application
  2. 6.1.1 Global Latanoprost Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Latanoprost Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Latanoprost Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Latanoprost Sales by Application
  6. 6.2.1 Global Latanoprost Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Latanoprost Sales by Application (2021-2032) & (M Unit)
  8. 6.2.3 Global Latanoprost Sales Market Share by Application (2021-2032)
  9. 6.3 Global Latanoprost Price by Application
7 Company Profiles
  1. 7.1 Pfizer
  2. 7.1.1 Pfizer Company Information
  3. 7.1.2 Pfizer Business Overview
  4. 7.1.3 Pfizer Latanoprost Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer Latanoprost Product Portfolio
  6. 7.1.5 Pfizer Recent Developments
  7. 7.2 Mylan
  8. 7.2.1 Mylan Company Information
  9. 7.2.2 Mylan Business Overview
  10. 7.2.3 Mylan Latanoprost Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mylan Latanoprost Product Portfolio
  12. 7.2.5 Mylan Recent Developments
  13. 7.3 Novartis
  14. 7.3.1 Novartis Company Information
  15. 7.3.2 Novartis Business Overview
  16. 7.3.3 Novartis Latanoprost Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis Latanoprost Product Portfolio
  18. 7.3.5 Novartis Recent Developments
  19. 7.4 Apotex
  20. 7.4.1 Apotex Company Information
  21. 7.4.2 Apotex Business Overview
  22. 7.4.3 Apotex Latanoprost Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Apotex Latanoprost Product Portfolio
  24. 7.4.5 Apotex Recent Developments
  25. 7.5 Teva
  26. 7.5.1 Teva Company Information
  27. 7.5.2 Teva Business Overview
  28. 7.5.3 Teva Latanoprost Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Teva Latanoprost Product Portfolio
  30. 7.5.5 Teva Recent Developments
  31. 7.6 Taj Pharma
  32. 7.6.1 Taj Pharma Company Information
  33. 7.6.2 Taj Pharma Business Overview
  34. 7.6.3 Taj Pharma Latanoprost Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Taj Pharma Latanoprost Product Portfolio
  36. 7.6.5 Taj Pharma Recent Developments
  37. 7.7 CR Zizhu
  38. 7.7.1 CR Zizhu Company Information
  39. 7.7.2 CR Zizhu Business Overview
  40. 7.7.3 CR Zizhu Latanoprost Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 CR Zizhu Latanoprost Product Portfolio
  42. 7.7.5 CR Zizhu Recent Developments
8 North America
  1. 8.1 North America Latanoprost Market Size by Type
  2. 8.1.1 North America Latanoprost Revenue by Type (2021-2032)
  3. 8.1.2 North America Latanoprost Sales by Type (2021-2032)
  4. 8.1.3 North America Latanoprost Price by Type (2021-2032)
  5. 8.2 North America Latanoprost Market Size by Application
  6. 8.2.1 North America Latanoprost Revenue by Application (2021-2032)
  7. 8.2.2 North America Latanoprost Sales by Application (2021-2032)
  8. 8.2.3 North America Latanoprost Price by Application (2021-2032)
  9. 8.3 North America Latanoprost Market Size by Country
  10. 8.3.1 North America Latanoprost Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Latanoprost Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Latanoprost Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Latanoprost Market Size by Type
  2. 9.1.1 Europe Latanoprost Revenue by Type (2021-2032)
  3. 9.1.2 Europe Latanoprost Sales by Type (2021-2032)
  4. 9.1.3 Europe Latanoprost Price by Type (2021-2032)
  5. 9.2 Europe Latanoprost Market Size by Application
  6. 9.2.1 Europe Latanoprost Revenue by Application (2021-2032)
  7. 9.2.2 Europe Latanoprost Sales by Application (2021-2032)
  8. 9.2.3 Europe Latanoprost Price by Application (2021-2032)
  9. 9.3 Europe Latanoprost Market Size by Country
  10. 9.3.1 Europe Latanoprost Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Latanoprost Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Latanoprost Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Latanoprost Market Size by Type
  2. 10.1.1 China Latanoprost Revenue by Type (2021-2032)
  3. 10.1.2 China Latanoprost Sales by Type (2021-2032)
  4. 10.1.3 China Latanoprost Price by Type (2021-2032)
  5. 10.2 China Latanoprost Market Size by Application
  6. 10.2.1 China Latanoprost Revenue by Application (2021-2032)
  7. 10.2.2 China Latanoprost Sales by Application (2021-2032)
  8. 10.2.3 China Latanoprost Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Latanoprost Market Size by Type
  2. 11.1.1 Asia Latanoprost Revenue by Type (2021-2032)
  3. 11.1.2 Asia Latanoprost Sales by Type (2021-2032)
  4. 11.1.3 Asia Latanoprost Price by Type (2021-2032)
  5. 11.2 Asia Latanoprost Market Size by Application
  6. 11.2.1 Asia Latanoprost Revenue by Application (2021-2032)
  7. 11.2.2 Asia Latanoprost Sales by Application (2021-2032)
  8. 11.2.3 Asia Latanoprost Price by Application (2021-2032)
  9. 11.3 Asia Latanoprost Market Size by Country
  10. 11.3.1 Asia Latanoprost Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Latanoprost Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Latanoprost Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Latanoprost Market Size by Type
  2. 12.1.1 SAMEA Latanoprost Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Latanoprost Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Latanoprost Price by Type (2021-2032)
  5. 12.2 SAMEA Latanoprost Market Size by Application
  6. 12.2.1 SAMEA Latanoprost Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Latanoprost Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Latanoprost Price by Application (2021-2032)
  9. 12.3 SAMEA Latanoprost Market Size by Country
  10. 12.3.1 SAMEA Latanoprost Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Latanoprost Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Latanoprost Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Latanoprost Value Chain Analysis
  2. 13.1.1 Latanoprost Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Latanoprost Production Mode & Process
  6. 13.2 Latanoprost Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Latanoprost Distributors
  9. 13.2.3 Latanoprost Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst